According to Future Market Insights (FMI) analysis in a recent market survey, the global single-use gastroscopes market was valued at USD 167.2 Million in 2022 and is expected to reach USD 807.8 Million by 2033.
Market Outlook:
Data Points | Market Insights |
---|---|
Market Value 2022 | USD 167.2 Million |
Market Value 2023 | USD 188.9 Million |
Market Value 2033 | USD 807.8 Million |
CAGR 2023 to 2033 | 15.6% |
Share of Top 5 Countries | 56.4% |
Key Players | Ambu A/S; Boston Scientific Corporation; Fujifilm Holdings Corporation; HOYA Corporation; Olympus Corporation; Pentax Medical; KARL STORZ SE & Co. KG; Medtronic; Cook Medical; Richard Wolf GmbH; OBP Medical Corporation; Hill Rom Holdings; Parburch Medical; Flexicare Medical Ltd. & AirStrip Technologies. |
Single-use gastroscopes are endoscopes that are designed to be used only once and then disposed of, rather than being cleaned and reprocessed for multiple uses. These devices are used to examine the inside of stomach and intestines, and can be used to diagnose a variety of gastrointestinal conditions, such as ulcers, tumors, and inflammation.
Single-use gastroscopes are typically used for diagnostic procedures such as upper GI endoscopies or colonoscopies. The devices are inserted into the patient's gastrointestinal tract to examine the lining of the esophagus, stomach, and intestines. The gastroscopes include a light source, a camera, and other tools for taking biopsies or removing polyps.
Single-use gastroscopes are available from a range of manufacturers and may vary in design and specifications. They are typically marketed as sterile and single-use only, and should not be reused. The devices should be disposed of in accordance with local regulations for medical waste.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of single-use gastroscopes market grew at a CAGR of 12.4% between 2017 and 2022. Single-use gastroscopes market contributes 16.7% revenue share to the global disposable endoscopy market was valued at USD 1.0 Billion in 2022.
The sales of single-use or disposable gastroscopes have been increasing in recent years due to several factors. One of the main reasons is the increasing demand for minimally invasive procedures. Gastrointestinal endoscopy is a minimally invasive diagnostic and therapeutic procedure that is becoming increasingly popular as patients seek less invasive alternatives to surgery. Single-use gastroscopes provide a safe and effective option for performing these procedures.
Another reason for the boost in sales is the increasing focus on infection control and prevention in healthcare settings. Single-use gastroscopes eliminate the risk of cross-contamination between patients, making them an attractive option for healthcare providers who want to reduce the risk of infections.
Advancements in technology are driving the development of new and improved gastroscopes with improved imaging capabilities, higher resolution cameras and advanced imaging technologies such as narrow-band imaging (NBI) and auto fluorescence & enhanced maneuverability. Advances in materials science and engineering are allowing for the development of more flexible and maneuverable single-use gastroscopes. This can improve the ability of healthcare providers to visualize and access hard-to-reach areas of the gastrointestinal tract.
However, it is important to note that the actual prevalence of gastric ulcers may be higher, as many cases may go undiagnosed or asymptomatic.
Considering this, FMI expects the global single-use gastroscopes market to grow at a CAGR of 15.6% through the forecasted years.
Single-use gastroscopes is growing with growing demand for minimally invasive diagnostic and therapeutic procedures in gastroenterology. Single-use gastroscopes, also known as disposable gastroscopes, offer several advantages over traditional reusable gastroscopes, such as eliminating the risk of cross-contamination, reducing the need for sterilization, and improving efficiency in endoscopy units.
Increasing gastrointestinal disorders and diseases, such as inflammatory bowel disease, gastroesophageal reflux disease, and gastrointestinal cancers is set to propel the global market. The use of disposable gastroscopes facilitate earlier diagnosis and treatment of these conditions, potentially improving patient outcomes and reducing healthcare costs.
Moreover, the market for single-use gastroscopes is expected to grow in the coming years, driven by factors such as the need for cost-effective endoscopic procedures and the increasing adoption of single-use medical devices in healthcare facilities.
Overall, single-use gastroscopes represent a promising opportunity for both healthcare providers and medical device manufacturers, offering a range of benefits over traditional reusable gastroscopes and addressing key challenges in the field of gastroenterology.
Single-use gastroscopes may be more expensive than traditional reusable gastroscopes. Although the cost of disposable gastroscopes has decreased in recent years, they still tend to be costlier per procedure compared to reusable devices. This may limit their adoption, particularly in resource-limited settings or in facilities with limited budgets.
There may be concerns regarding the environmental impact of single-use devices. Disposable gastroscopes generate more medical waste compared to reusable devices, which may have a negative impact on the environment. Healthcare providers and policymakers are required to balance the potential benefits of single-use gastroscopes with their environmental impact.
Single-use gastroscopes may not be suitable for all types of endoscopic procedures. For example, some complex procedures may require specialized or customized scopes that are not available as disposable devices. Additionally, some physicians may prefer the tactile feedback and durability of traditional reusable gastroscopes.
The use of single-use gastroscopes may require additional training for healthcare providers. Physicians and nurses may need to learn new techniques for handling, using, and disposing of disposable devices, which may increase the learning curve and add to the overall cost of the procedure.
Overall, while single use gastroscopes offer several potential benefits, their adoption may be limited by their cost, environmental impact, suitability for certain procedures, and the need for additional training.
These factors are expected to hamper revenue growth of the single-use gastroscopes market over the forecast period.
The USA single-use gastroscopes market held a market share of 94.5% of the North American market in 2022.
USA is one of the largest markets for single-use gastroscopes. The increasing prevalence of gastrointestinal disorders and diseases, the growing demand for minimally invasive procedures, and the need for cost-effective endoscopic devices are expected to drive market growth in the coming years.
The American Society for Gastrointestinal Endoscopy (ASGE) is a professional organization dedicated to advancing the practice of gastrointestinal endoscopy for the benefit of patients. The ASGE provides training and education for endoscopists, promotes research and innovation in the field, and advocates for quality standards and patient safety.
The use of single use gastroscopes is becoming increasingly common in clinical practice. The USA Food and Drug Administration (FDA) has approved several models of disposable gastroscopes for use in diagnostic and therapeutic procedures, such as esophagogastroduodenoscopy (EGD) and colonoscopy.
Due to the high incidence of conditions like chronic gastritis, GERD, there will be a high adoption rate of gastroscopy procedure creating demand for disposable gastroscopes.
Germany dominated the Western Europe market for single-use gastroscopes and accounted for around 26.7% of the market share in 2022.
Germany has been one of the leading countries in Europe in terms of using single-use medical equipment, including single-use gastroscopes. This trend is partly driven by concerns about infection control and patient safety. Single-use gastroscopes are seen as a way to reduce the risk of transmitting infectious diseases such as hepatitis or HIV between patients.
Additionally, single-use gastroscopes are often considered more convenient and time-efficient than reusable ones since there is no need to clean and sterilize the equipment after each use. However, some experts have raised concerns about the environmental impact of disposable medical equipment and the potential for increased healthcare costs associated with single-use items.
China is projected to be the most attractive market in the single-use gastroscopes, and held market share of 56.5% in 2022.
The single-use gastroscopes market in China is expected to grow significantly in the coming years due to several factors.
China has a large population, and the demand for medical procedures is high. Single-use medical equipment, including single-use gastroscopes, are often seen as a way to increase efficiency and productivity in the healthcare system, as there is no need to spend time cleaning and sterilizing the equipment between uses.
While the use of single-use gastroscopy in China has advantages in terms of infection control and convenience, there are also concerns about the environmental impact and the potential increase in healthcare costs associated with the use of disposable medical equipment. As with any medical technology, the use of single-use gastroscopy in China should be carefully evaluated to ensure that it provides the best possible outcomes for patients while minimizing any negative impacts.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The GERD segment held the major chunk of about 34.5% in global market by the end of 2022.
The use of single-use gastroscopy in the diagnosis and treatment of GERD is similar to its use in other gastroenterological procedures. Single-use gastroscopes are often seen as a way to reduce the risk of infection transmission between patients and improve efficiency in the healthcare system.
In the United States, it is estimated that approximately 20% of the population experiences GERD symptoms at least once a week, with an estimated 10% experiencing symptoms on a daily basis. The prevalence of GERD is higher in older adults, with approximately 30% of adults over the age of 65 experiencing symptoms on a regular basis as per National Library of Medicine in 2022.
GERD can be diagnosed during gastroscopy by observing changes in the esophageal lining, such as inflammation or irritation, that are consistent with acid reflux. Additionally, the presence of complications such as esophageal strictures, ulcers, or Barrett's esophagus (a precancerous condition) can also be assessed during gastroscopy.
The hospitals segment accounted for revenue share of 46.6% in the global market at the end of 2022.
Hospitals are one of the primary settings where single-use gastroscopy is used. In recent years, there has been an increase in the adoption of single-use gastroscopes in hospitals around the world, driven by a variety of factors including infection control concerns, convenience, and cost.
One advantage of single-use gastroscopy in the hospital setting is that it can help reduce the risk of infection transmission between patients. With reusable gastroscopes, there is a risk of cross-contamination if the equipment is not properly cleaned and sterilized between uses. Single-use gastroscopes eliminate this risk, as they are used only once and then disposed of, reducing the potential for infection transmission.
Key players in the market are focused on increase their product portfolio to strengthen their position in the single-use gastroscopes market, and also to expand their footprint in emerging markets. The key strategy adopted by manufacturers to gain competitive edge in the market are the pricing strategies, market strategies, technological advancements, regulatory compliance and acquisition & distribution agreement of other companies to expand their business.
For instance:
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the single-use gastroscopes market space, which are available in the full report
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2017 to 2022 |
Market Analysis | USD Million for Value |
Key Regions Covered | North America; Latin America; East Asia; South Asia & Pacific; Western Europe; Eastern Europe; Central Asia; Russia & Belarus; Balkan & Baltic Countries and Middle East and Africa (MEA). |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Italy, Spain, Russia, BENELUX, Nordics, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, Poland, Hungary, Romania, Czech Republic, Türkiye, South Africa, North Africa, GCC Countries, Kingdom of Saudi Arabia & Israel. |
Key Segments Covered | Application, End User and Region |
Key Companies Profiled | Ambu A/S; Boston Scientific Corporation; Fujifilm Holdings Corporation; HOYA Corporation; Olympus Corporation; Pentax Medical; KARL STORZ SE & Co. KG; Medtronic; Cook Medical; Richard Wolf GmbH; OBP Medical Corporation; Hill Rom Holdings; Parburch Medical; Flexicare Medical Ltd.; AirStrip Technologies |
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
The market is estimated to secure a valuation of USD 188.9 million in 2023.
The growth potential of the market is 15.6% CAGR through 2033.
The global market size to reach USD 807.8 million by 2033.
Medtronic, Cook Medical, and Ambu A/S are the key market players.
High demand for medical procedures raises the China market.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value Added Insights 5. Market Background 6. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 7.1. GERD 7.2. Chronic Gastritis 7.3. Gastric Ulcers 7.4. Barrett's Esophagus 7.5. Others 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 8.1. Hospitals 8.2. Ambulatory Surgical Centers 8.3. Specialty Clinics 8.4. Diagnostic Centers 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 9.1. North America 9.2. Latin America 9.3. East Asia 9.4. South Asia & Pacific 9.5. Western Europe 9.6. Eastern Europe 9.7. Central Asia 9.8. Russia & Belarus 9.9. Balkan & Baltic Countries 9.10. Middle East and Africa (MEA) 10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 12. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13. South Asia & Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16. Central Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17. Russia & Belarus Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18. Balkan & Baltic Countries Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20. Market Structure Analysis 21. Competition Analysis 21.1. Ambu A/S 21.2. Boston Scientific Corporation 21.3. Fujifilm Holdings Corporation 21.4. HOYA Corporation 21.5. Olympus Corporation 21.6. Pentax Medical 21.7. KARL STORZ SE & Co. KG 21.8. Medtronic 21.9. Cook Medical 21.10. Richard Wolf GmbH 21.11. OBP Medical Corporation 21.12. Hill Rom Holdings 21.13. Parburch Medical 21.14. Flexicare Medical Ltd. 21.15. AirStrip Technologies 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports